A range of cosmetics ingredients will face additional screening for potentially causing adverse effects when interacting with the hormone systems of people and animals, an European Commission conference on 1 June in Brussels has heard.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.